by Yosef
On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for […]
by Yosef
Below are links to eighteen publications describing clinical studies of ASPS with novel treatments as well […]
by Yosef
We selected to highlight 3 studies that were presented this year at the ASCO conference: 1. Treatment […]
by Yosef
An experimental drug, cediranib, may benefit alveolar soft part sarcoma (ASPS) patients, according a recent clinical […]
by Yosef
For Alveolar Soft Part Sarcoms patients the use of aggressive surgery, appropriate diagnostic imaging, and long-term surveillance for […]
by Yosef
Lung metastases affect a significant part of the ASPS patients at some point of their life, […]
by Yosef
Stereotactic Radiosurgery (SRS) is a medical procedure, which is non-invasive surgery to destroy tumors. High dose […]